Millennium Management’s Albany Molecular Research Inc AMRI Stock Holding History

Millennium Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-23,142	Closed	-$325K	–	4145
2017 Q1	$325K	Buy	+23,142	New	+$379K	﹤0.01%	3010
2016 Q1	–	Sell	-56,053	Closed	-$1.11M	–	3902
2015 Q4	$1.11M	Buy	56,053 +32,817	+141%	+$624K	﹤0.01%	2251
2015 Q3	$405K	Buy	+23,236	New	+$473K	﹤0.01%	2767
2015 Q1	–	Sell	-227,784	Closed	-$3.71M	–	4395
2014 Q4	$3.71M	Sell	227,784 -701,692	-75%	-$12.9M	0.01%	1587
2014 Q3	$20.5M	Buy	929,476 +19,343	+2%	+$396K	0.05%	491
2014 Q2	$18.3M	Sell	910,133 -112,048	-11%	-$1.9M	0.05%	512
2014 Q1	$19M	Buy	1,022,181 +967,629	+1,774%	+$13.3M	0.06%	472
2013 Q4	$550K	Buy	+54,552	New	+$659K	﹤0.01%	2656
2013 Q3	–	Sell	-37,791	Closed	-$449K	–	3728
2013 Q2	$449K	Buy	+37,791	New	+$409K	﹤0.01%	2393

Other funds holding AMRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Millennium Management's AMRI Position: Q2 2017 in Review

Millennium Management sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 23,142 shares — an estimated $325K sold.

Millennium Management first reported a position in AMRI in Q2 2013 and held it in 9 quarters. The position peaked at $20.5M in Q3 2014. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

Millennium Management reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
Millennium Management sold 23,142 Albany Molecular Research Inc shares in Q2 2017, an estimated $325K.
Millennium Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 9 quarters.
Millennium Management's Albany Molecular Research Inc position peaked at $20.5M in Q3 2014.
136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Millennium Management's 13F filing for Q2 2017, filed 14 Aug 2017.